PRNP Specific Neutra™ Antibody Products
Product listAccelerate Your Research and Development!
Are you currently facing challenges in understanding prion diseases, developing diagnostics for neurodegenerative conditions, or needing highly specific tools for neurological research? Creative Biolabs’ Prion Protein (PRNP) Specific Antibody Products help you accelerate your neurological research, obtain precise detection of PrP isoforms, and develop robust assays through advanced antibody engineering and comprehensive characterization.
Contact our team to get an inquiry now!
Introduction of PRNP
Prion protein (PrP), encoded by the PRNP gene, is a highly conserved glycoprotein found ubiquitously in mammals, with particularly high expression levels in the central and peripheral nervous systems. The normal cellular isoform, PrPC, is a glycosylphosphatidylinositol (GPI)-anchored protein predominantly located on the outer membrane of neurons. Structurally, PrPC is characterized by a flexible N-terminal tail and a structured C-terminal core rich in α-helices and two small β-sheets. While its precise physiological function remains under active investigation, PrPC has been implicated in a wide range of cellular processes, including myelin homeostasis, neuroprotection, circadian rhythm regulation, metal ion homeostasis, mitochondrial homeostasis, and intercellular signaling. It is present in both pre- and post-synaptic compartments, suggesting roles in synaptic function and neuronal development.
The pathological hallmark of prion diseases, also known as transmissible spongiform encephalopathies (TSEs), is the misfolding of PrPC into an abnormal, disease-associated infectious isoform, PrPSc (scrapie PrP). Unlike PrPC, PrPSc is characterized by a high percentage of β-sheets, making it highly resistant to proteolysis and denaturation. This misfolded PrPSc acts as a template, inducing the conformational change of normal PrPC into further PrPSc molecules, leading to an exponential cascade of aggregation. These aggregates accumulate in infected tissues, particularly the brain, causing characteristic spongiform degeneration, neuronal death, astrocytosis, and amyloid plaque formation.
Prion diseases are progressive, invariably fatal neurodegenerative illnesses with no known effective treatments. Examples comprise Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE) among cattle, scrapie in sheep, and chronic wasting disease (CWD) in cervids. Transmission can occur sporadically, genetically (due to mutations in the PRNP gene), or through exposure to infected tissues. The poor immunogenicity of prion proteins has historically limited vaccination attempts, highlighting the critical need for highly specific antibodies to study and potentially inhibit prion pathogenesis.
Fig. 1 Anti-prion protein antibody (Ab) influences PrPC and PrPSc biological functions.1
Antibodies Against PRNP
Antibodies targeting the Prion Protein (PRNP) are indispensable tools for both fundamental research into prion biology and the development of diagnostic strategies for prion diseases. Given the critical difference in conformation between the normal cellular form (PrPC) and the pathogenic misfolded form (PrPSc), antibodies can be developed to specifically recognize either or both isoforms. This precision is critical for exact identification and discrimination within research and diagnostics.
The applications of anti-PRNP antibodies are diverse and critical for advancing our understanding and management of prion-related conditions:
- Diagnosis of Prion Diseases: Antibodies are central to immunoassays used for the post-mortem diagnosis of TSEs, such as CJD, BSE, and scrapie. They can detect the protease-resistant PrPSc in brain tissue, which is a definitive marker of infection.
- Research into Pathogenesis: Anti-PrP antibodies are used to study the mechanisms of PrP misfolding, aggregation, and neurotoxicity. They can help elucidate the cellular pathways involved in prion propagation and the host response to infection.
- Drug Discovery and Therapeutic Development: Antibodies can be employed in high-throughput screening assays to identify compounds that inhibit PrP misfolding or promote its clearance. Furthermore, as demonstrated by early research, anti-PrP antibodies have shown potential in preventing prion pathogenesis in vivo. For instance, transgenic expression of anti-prion protein μ chain in mice has been shown to prevent the pathogenesis of prions introduced by intraperitoneal injection in both the spleen and brain, suggesting the feasibility of immunological inhibition of prion disease.
- Biomarker Discovery: These antibodies are vital for identifying and validating new biomarkers for early detection of prion diseases, which is currently a significant challenge due to their long incubation periods.
- Quality Control and Safety: In industries dealing with biological products, anti-PrP antibodies can be used to screen for prion contamination, ensuring the safety of blood products, pharmaceuticals, and animal feeds.
- Cellular and Molecular Biology Studies: Scientists employ anti-PrP antibodies in methodologies including Western blotting for PrP expression analysis, immunohistochemistry/immunofluorescence for tissue/cellular PrP visualization, and ELISA to quantify levels in diverse biological fluids.
The ability of these antibodies to bind specifically to PrP isoforms makes them invaluable reagents for dissecting the complex biology of prions and developing much-needed diagnostic and therapeutic strategies.
Why Choose Us?
Creative Biolabs is committed to providing superior Prion Protein (PRNP) Specific Antibody Products that meet the rigorous demands of neurological research and diagnostics. Our dedication to quality, specificity, and performance sets us apart, ensuring that your projects are supported by the most reliable reagents available.
Here are the key advantages of choosing Creative Biolabs:
- Unparalleled Specificity and Sensitivity: Our antibodies undergo stringent validation processes to ensure high specificity for their intended PrP isoforms and exceptional sensitivity, enabling the detection of even low concentrations of PrP in complex biological matrices. This reduces cross-reactivity and guarantees precise, dependable outcomes.
- Robust Performance Across Applications: Creative Biolabs’ anti-PRNP antibodies are optimized for consistent performance across a wide range of applications, including ELISA, Western Blotting, Immunohistochemistry (IHC), and Immunofluorescence (IF). This versatility provides researchers with flexible tools for their diverse experimental needs.
- Expertise in Neurodegenerative Research: With extensive experience in the field of biology and neurodegenerative diseases, Creative Biolabs possesses deep scientific knowledge essential for developing and characterizing antibodies against challenging targets like prion proteins. Our expertise translates directly into the quality and reliability of our products.
- Comprehensive Characterization: Every antibody product is thoroughly characterized for purity, concentration, and binding affinity, ensuring lot-to-lot consistency and reproducibility in your experiments.
- Commitment to Innovation: We continuously invest in research and development to bring cutting-edge antibody solutions to the market, addressing emerging needs in prion research and diagnostics.
FAQs
Q: What are prion proteins, and why are they important in research?
A: Prion proteins are endogenous bodily proteins, predominantly located in the brain. They are crucial in research because their misfolding into an abnormal form is the underlying cause of a group of fatal neurodegenerative diseases known as prion diseases, such as Creutzfeldt-Jakob disease. Studying these proteins is essential for understanding disease mechanisms, developing diagnostics, and exploring potential therapeutic interventions for these challenging conditions.
Q: How can antibodies help in detecting different forms of prion protein?
A: Antibodies are highly specific tools that can be engineered to recognize subtle differences in protein structure. For prion proteins, this means antibodies can be developed to distinguish between the normal, healthy form and the misfolded, disease-associated form. This differential recognition is critical for diagnostic tests and research studies aiming to identify the presence of pathogenic prions in biological samples.
Q: What are the primary applications for these prion protein antibodies?
A: These immunoglobulins are adaptable and are employed across multiple applications. They are commonly employed in techniques like Western blotting to identify protein presence and size, immunohistochemistry to visualize protein distribution in tissues, and ELISA for quantitative measurements in fluids. They are invaluable for diagnosing prion diseases, studying disease progression, and screening for potential therapeutic compounds.
Access the Creative Biolabs Edge – Request Your Quote Now
REFERENCE
- Rovis, Tihana Lenac, and Giuseppe Legname. “Prion protein-specific antibodies-development, modes of action and therapeutics application.” Viruses vol. 6,10 3719-37. 1 Oct. 2014, DOI:10.3390/v6103719. Distributed under Open Access license CC BY 4.0, without modification.
